{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:55:58Z","timestamp":1784735758422,"version":"3.55.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/01874"],"award-info":[{"award-number":["PI17\/01874"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/01874"],"award-info":[{"award-number":["PI17\/01874"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Venous thromboembolism (VTE) in pregnancy is an important cause of maternal morbidity and mortality. Low-molecular-weight heparin (LMWH) is the cornerstone of prophylaxis and treatment of thrombotic events during pregnancy. LMWH has fewer adverse effects than other anticoagulants, does not cross the placenta, and is safe for the fetus. However, the use of LMWH during pregnancy is sensitive to womens\u2019 underlying preferences. The objective of this review is to systematically assess women\u2019s values and preferences research evidence on this topic.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We searched four electronic databases from inception to March 2022, and included studies examining values and preferences of using LMWH among pregnant women at risk of VTE. We followed a convergent integrated mixed-methods design to compare and contrast quantitative\u00a0outcomes (utility and non-utility measures) and qualitative findings. We assessed the certainty of the values and preferences evidence with the GRADE approach for quantitative findings, and with GRADE-CERqual for qualitative evidence. Results were presented in a conjoint display.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We screened 3,393 references and identified seven eligible studies. The mixed methods analysis resulted in four themes. Datasets confirmed each other in that: 1) the majority of women consider that benefits of treatment outweigh the inconveniences of daily injections; and 2) main concerns around medication are safety and injections administration. Quantitative outcomes expanded on the qualitative findings in that: 3) participants who perceived a higher risk of VTE were more willing to take LMWH. Finally, we found a discrepancy between the datasets around: 4) the amount of information preferred to make the decision; however, qualitative data expanded to clarify that women prefer making informed decisions and receive support from their clinician in their decision-making process.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We are moderately confident that in the context of pregnancy, using LMWH is preferred by women given its net beneficial balance. Integrating data from different sources of evidence, and representing them in a jointly manner helps to identify patient\u2019s values and preferences. Our results may inform clinical practice guidelines and support shared decision-making process in the clinical encounter for the management of VTE in the context of pregnancy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-022-05042-x","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T09:05:03Z","timestamp":1664960703000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Women\u2019s values and preferences on low-molecular-weight heparin and pregnancy: a mixed-methods systematic review"],"prefix":"10.1186","volume":"22","author":[{"given":"Montserrat","family":"Le\u00f3n-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Maraboto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Rabassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasey R.","family":"Boehmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilisbeth","family":"Perestelo-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Pelayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Eckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Selva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Alonso-Coello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,5]]},"reference":[{"key":"5042_CR1","doi-asserted-by":"crossref","unstructured":"Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: A 30-year population-based study.\u00a0Ann Intern Med. 2005;143(10):697\u2013707.","DOI":"10.7326\/0003-4819-143-10-200511150-00006"},{"issue":"1","key":"5042_CR2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/ijgo.12764","volume":"145","author":"J Bailly","year":"2019","unstructured":"Bailly J, Jacobson BF, Louw S. Safety and efficacy of adjusted-dose enoxaparin in pregnant patients with increased risk for venous thromboembolic disease. Int J Gynaecol and Obstet. 2019;145(1):70\u20135.","journal-title":"Int J Gynaecol and Obstet"},{"key":"5042_CR3","unstructured":"MBRRACE-UK. Saving lives, improving mother\u2019s care report. MBRRACE-UK. Midwifery. 2019;31:1\u201385."},{"issue":"1","key":"5042_CR4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/1076029616675967","volume":"24","author":"R Nahas","year":"2018","unstructured":"Nahas R, Saliba W, Elias A, Elias M. The prevalence of thrombophilia in women with recurrent fetal loss and outcome of anticoagulation therapy for the prevention of miscarriages. Clin Appl Thromb\/Hemost. 2018;24(1):122\u20138.","journal-title":"Clin Appl Thromb\/Hemost"},{"issue":"1","key":"5042_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-019-1183-3","volume":"19","author":"J Zheng","year":"2019","unstructured":"Zheng J, Chen Q, Fu J, Lu Y, Han T, He P. Critical appraisal of international guidelines for the prevention and treatment of pregnancy-associated venous thromboembolism: a systematic review. BMC Cardiovasc Disord. 2019;19(1):1\u201310.","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"5042_CR6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/jth.12085","volume":"11","author":"E Romualdi","year":"2013","unstructured":"Romualdi E, Dentali F, Rancan E, Squizzato A, Steidl L, Middeldorp S, et al. Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature. J Thromb Haemost. 2013;11(2):270\u201381.","journal-title":"J Thromb Haemost"},{"key":"5042_CR7","first-page":"48","volume":"80","author":"C Sucker","year":"2020","unstructured":"Sucker C. Prophylaxis and therapy of venous thrombotic events in pregnancy and the postpartum period. GebFra Science. 2020;80:48\u201359.","journal-title":"GebFra Science"},{"issue":"6","key":"5042_CR8","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1182\/blood-2013-01-478958","volume":"123","author":"MA Rodger","year":"2014","unstructured":"Rodger MA, Carrier M, le Gal G, Martinelli I, Perna A, Rey E, et al. Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications. Blood. 2014;123(6):822\u20138.","journal-title":"Blood"},{"key":"5042_CR9","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/S0049-3848(17)30065-8","volume":"151","author":"L Skeith","year":"2017","unstructured":"Skeith L, Rodger M. Anticoagulants to prevent recurrent placenta-mediated pregnancy complications: is it time to put the needles away? Thromb Res. 2017;151:S38-42.","journal-title":"Thromb Res"},{"issue":"3","key":"5042_CR10","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1213\/ANE.0000000000002530","volume":"126","author":"L Leffert","year":"2018","unstructured":"Leffert L, Butwick A, Carvalho B, Arendt K, Bates SM, Friedman A, et al. The society for obstetric anesthesia and perinatology consensus statement on the anesthetic management of pregnant and postpartum women receiving thromboprophylaxis or higher dose anticoagulants. Anesth Analg. 2018;126(3):928\u201344.","journal-title":"Anesth Analg"},{"issue":"2 SUPPL.","key":"5042_CR11","doi-asserted-by":"publisher","first-page":"e1S","DOI":"10.1378\/chest.11-2290","volume":"141","author":"S MacLean","year":"2012","unstructured":"MacLean S, Mulla S, Akl EA, Jankowski M, Vandvik PO, Ebrahim S, et al. Patient values and preferences in decision making for antithrombotic therapy: a systematic review - antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 SUPPL.):e1S-e23S.","journal-title":"Chest"},{"issue":"22","key":"5042_CR12","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","volume":"2","author":"SM Bates","year":"2018","unstructured":"Bates SM, Rajasekhar A, Middeldorp S, McLintock C, Rodger MA, James AH, et al. American society of hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv. 2018;2(22):3317\u201359.","journal-title":"Blood Adv"},{"issue":"5","key":"5042_CR13","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1182\/bloodadvances.2019000462","volume":"4","author":"I Etxeandia-Ikobaltzeta","year":"2020","unstructured":"Etxeandia-Ikobaltzeta I, Zhang Y, Brundisini F, Florez ID, Wiercioch W, Nieuwlaat R, et al. Patient values and preferences regarding VTE disease: a systematic review to inform American society of hematology guidelines. Blood Adv. 2020;4(5):953\u201368.","journal-title":"Blood Adv"},{"issue":"2","key":"5042_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1258\/jhsrp.2007.007074","volume":"13","author":"A O\u2019Cathain","year":"2008","unstructured":"O\u2019Cathain A, Murphy E, Nicholl J. The quality of mixed methods studies in health services research. J Health Serv Res Policy. 2008;13(2):92\u20138.","journal-title":"J Health Serv Res Policy"},{"key":"5042_CR15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/1558689819834753","volume":"13","author":"MD Fetters","year":"2019","unstructured":"Fetters MD, Molina-Azorin JF. New requirements to include the methodological contribution in articles published in the journal of mixed methods research. J Mixed Methods Res. 2019;13:138\u201342.","journal-title":"J Mixed Methods Res"},{"issue":"7","key":"5042_CR16","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s00198-019-04913-y","volume":"30","author":"JEM Sale","year":"2019","unstructured":"Sale JEM, Marwah A, Naeem F, Yu W, Meadows L. Evidence of patient beliefs, values, and preferences is not provided in osteoporosis clinical practice guidelines. Osteoporos Int. 2019;30(7):1325\u201337.","journal-title":"Osteoporos Int"},{"issue":"8","key":"5042_CR17","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s11606-009-0987-8","volume":"24","author":"CAKY Chong","year":"2009","unstructured":"Chong CAKY, Chen IJ, Naglie G, Krahn MD. How well do guidelines incorporate evidence on patient preferences? J Gen Intern Med. 2009;24(8):977\u201382.","journal-title":"J Gen Intern Med"},{"key":"5042_CR18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jclinepi.2019.08.008","volume":"116","author":"A Selva","year":"2019","unstructured":"Selva A, Sanabria AJ, Ni\u00f1o de Guzman E, Ballesteros M, Selva C, Valli C, et al. Colorectal cancer guidelines seldom include the patient perspective. J Clin Epidemiol. 2019;116:84\u201397.","journal-title":"J Clin Epidemiol"},{"key":"5042_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2020-046021","volume":"11","author":"B Humphries","year":"2021","unstructured":"Humphries B, Le\u00f3n-Garcia M, Bates S, Guyatt G, Eckman M, Souza RD, et al. Decision Analysis in SHared decision making for Thromboprophylaxis during Pregnancy (DASH-TOP): a sequential explanatory mixed methods pilot study protocol. BMJ Open. 2021;11:1\u201312.","journal-title":"BMJ Open"},{"key":"5042_CR20","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. British Med J. 2021;372(n71):1\u201320.","DOI":"10.1136\/bmj.n71"},{"key":"5042_CR21","unstructured":"Creswell JW, Plano Clark VL. Designing and Conducting Mixed Methods Research [Internet]. Third Edit. SAGE Publications, Inc; 2017. 520 p. Available from: https:\/\/us.sagepub.com\/en-us\/nam\/designing-and-conducting-mixed-methods-research\/book241842"},{"issue":"6","key":"5042_CR22","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1370\/afm.1865","volume":"13","author":"TC Guetterman","year":"2015","unstructured":"Guetterman TC, Fetters MD, Creswell JW. Integrating quantitative and qualitative results in health science mixed methods research through joint displays. Ann Fam Med. 2015;13(6):554\u201361.","journal-title":"Ann Fam Med"},{"key":"5042_CR23","unstructured":"Sandelowski M, Voils CI, Barroso J. Defining and Designing Mixed Research Synthesis Studies. Res sch [Internet]. 2006;13(1):29. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3624763\/pdf\/nihms412728.pdf"},{"key":"5042_CR24","doi-asserted-by":"publisher","DOI":"10.4135\/9781506335193","volume-title":"Sage Handbook of Mixed Methods in Social & Behavioral Research","author":"A Tashakkori","year":"2010","unstructured":"Tashakkori A, Teddlie C. Sage Handbook of Mixed Methods in Social & Behavioral Research. 2nd ed. Thousand Oaks, CA: Sage Publications; 2010.","edition":"2"},{"issue":"3","key":"5042_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/XEB.0000000000000052","volume":"13","author":"A Pearson","year":"2015","unstructured":"Pearson A, White H, Bath-Hextall F, Salmond S, Apostolo J, Kirkpatrick P. A mixed-methods approach to systematic reviews. Int J Evid Based Healthc. 2015;13(3):121\u201331.","journal-title":"Int J Evid Based Healthc"},{"issue":"6 PART2","key":"5042_CR26","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1111\/1475-6773.12117","volume":"48","author":"MD Fetters","year":"2013","unstructured":"Fetters MD, Curry LA, Creswell JW. Achieving integration in mixed methods designs - Principles and practices. Health Services Res. 2013;48(6 PART2):2134\u201356.","journal-title":"Health Services Res"},{"issue":"4","key":"5042_CR27","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s11136-016-1423-2","volume":"26","author":"E Moseholm","year":"2017","unstructured":"Moseholm E, Rydahl-Hansen S, Lindhardt B, Fetters MD. Health-related quality of life in patients with serious non-specific symptoms undergoing evaluation for possible cancer and their experience during the process: a mixed methods study. Qual Life Res. 2017;26(4):993\u20131006.","journal-title":"Qual Life Res"},{"issue":"2","key":"5042_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/nur.10072","volume":"26","author":"M Sandelowski","year":"2003","unstructured":"Sandelowski M, Barroso J. Focus on research methods toward a metasynthesis of qualitative findings on motherhood in HIV-positive women. Res Nurs Health. 2003;26(2):153\u201370.","journal-title":"Res Nurs Health"},{"issue":"126","key":"5042_CR29","first-page":"1","volume":"15","author":"A Selva","year":"2017","unstructured":"Selva A, Sol\u00e0 I, Zhang Y, Pardo-hernandez H, Haynes RB, Garc\u00eda LM, et al. Development and use of a content search strategy for retrieving studies on patients \u2019 views and preferences. Health Qual Life Outcomes. 2017;15(126):1\u20139.","journal-title":"Health Qual Life Outcomes"},{"key":"5042_CR30","doi-asserted-by":"crossref","unstructured":"Campbell M, McKenzie JE, Sowden A, Katikireddi SV, Brennan SE, Ellis S, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: Reporting guideline.\u00a0 BMJ. 2020;368:1\u20136.","DOI":"10.1136\/bmj.l6890"},{"key":"5042_CR31","doi-asserted-by":"crossref","unstructured":"Zhang Y, Morgan RL, Alonso-Coello P, Wiercioch W, Ba\u0142a MM, Jaeschke RR, et al. A systematic review of how patients value COPD outcomes. Eur Respir J. 2018;52(1):180222.","DOI":"10.1183\/13993003.00222-2018"},{"key":"5042_CR32","doi-asserted-by":"crossref","unstructured":"Aromataris E, Munn Z. JBI Manual for Evidence Synthesis. JBI, 2020. [Internet]. 2020. Available from: https:\/\/wiki.jbi.global\/display\/MANUAL\/8.3+The+JBI+approach+to+mixed+method+systematic+reviews","DOI":"10.46658\/JBIMES-20-01"},{"key":"5042_CR33","volume-title":"Synthesizing qualitative evidence evidence","author":"A Pearson","year":"2011","unstructured":"Pearson A, Robertson-malt S, Rittenmeyer L. Synthesizing qualitative evidence evidence. 2011."},{"key":"5042_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jclinepi.2018.05.011","volume":"111","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Coello PA, Guyatt GH, Yepes-Nu\u00f1ez JJ, Akl EA, Hazlewood G, et al. GRADE guidelines: 20. Assessing the certainty of evidence in the importance of outcomes or values and preferences\u2014inconsistency, imprecision, and other domains. J Clin Epidemiol. 2019;111:83\u201393.","journal-title":"J Clin Epidemiol"},{"key":"5042_CR35","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jclinepi.2018.01.013","volume":"111","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Alonso-Coello P, Guyatt GH, Yepes-Nu\u00f1ez JJ, Akl EA, Hazlewood G, et al. GRADE guidelines: 19. Assessing the certainty of evidence in the importance of outcomes or values and preferences\u2014Risk of bias and indirectness. J Clin Epidemiol. 2019;111:94\u2013104.","journal-title":"J Clin Epidemiol"},{"key":"5042_CR36","unstructured":"CASP Qualitative Checklist. Critical appraisal skills programme part of better value healthcare Ltd. 2018. Available from: www.casp-uk.net"},{"key":"5042_CR37","doi-asserted-by":"crossref","unstructured":"Noyes J, Booth A, Moore G, Flemming K, Tun\u00e7alp \u00d6, Shakibazadeh E. Synthesising quantitative and qualitative evidence to inform guidelines on complex interventions: clarifying the purposes, designs and outlining some methods. BMJ Global Health. 2019;4(Supplement1):1\u201314.","DOI":"10.1136\/bmjgh-2018-000893"},{"key":"5042_CR38","doi-asserted-by":"crossref","unstructured":"Lewin S, Bohren M, Rashidian A, Munthe-Kaas H, Glenton C, Colvin CJ, et al. Applying GRADE-CERQual to qualitative evidence synthesis findings-paper 2: how to make an overall CERQual assessment of confidence and create a summary of qualitative findings table. Implementation Science. 2018;13(Suppl 1):1\u201370.","DOI":"10.1186\/s13012-017-0689-2"},{"key":"5042_CR39","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jclinepi.2021.11.026","volume":"142","author":"CA Cuello-Garcia","year":"2022","unstructured":"Cuello-Garcia CA, Santesso N, Morgan RL, Verbeek J, Thayer K, Ansari MT, et al. GRADE guidance 24 optimizing the integration of randomized and non-randomized studies of interventions in evidence syntheses and health guidelines. J Clin Epidemiol. 2022;142:200\u20138.","journal-title":"J Clin Epidemiol"},{"key":"5042_CR40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.thromres.2018.11.020","volume":"173","author":"B Guimicheva","year":"2019","unstructured":"Guimicheva B, Patel JP, Roberts LN, Subramanian D, Arya R. Women\u2019s views, adherence and experience with postnatal thromboprophylaxis. Thromb Res. 2019;173:85\u201390.","journal-title":"Thromb Res"},{"key":"5042_CR41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.thromres.2015.12.015","volume":"140","author":"SM Bates","year":"2016","unstructured":"Bates SM, Alonso-Coello P, Tikkinen KAO, Ebrahim S, Lopes LC, McDonald SD, et al. Women\u2019s values and preferences and health state valuations for thromboprophylaxis during pregnancy: a cross-sectional interview study. Thromb Res. 2016;140:22\u20139.","journal-title":"Thromb Res"},{"issue":"8","key":"5042_CR42","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3109\/01443615.2015.1009878","volume":"35","author":"CE Hordern","year":"2015","unstructured":"Hordern CE, Bircher CW, Prosser-Snelling EC, Fraser FK, Smith RP. Patient compliance with postnatal thromboprophylaxis: an observational study. J Obstet Gynaecol. 2015;35(8):793\u20136.","journal-title":"J Obstet Gynaecol"},{"key":"5042_CR43","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/nrcardio.2015.172","volume":"153","author":"DR Anderson","year":"1993","unstructured":"Anderson DR, Ginsberg JS, Brill-Edwards P, Demers C, Burrows RF, Hirsh J. The use of an indwelling Teflon catheter for subcutaneous heparin administration during pregnancy. Arch Intern Med. 1993;153:841\u20134. https:\/\/doi.org\/10.1038\/nrcardio.2015.172.","journal-title":"Arch Intern Med"},{"issue":"12","key":"5042_CR44","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1111\/jth.12020","volume":"10","author":"JP Patel","year":"2012","unstructured":"Patel JP, Auyeung V, Patel RK, Marsh MS, Green B, Arya R, et al. Women\u2019s views on and adherence to low-molecular-weight heparin therapy during pregnancy and the puerperium. J Thromb Haemost. 2012;10(12):2526\u201334.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"5042_CR45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1552-6909.2006.00113.x","volume":"36","author":"TZ Martens","year":"2007","unstructured":"Martens TZ, Emed JD. The experiences and challenges of pregnant women coping with thrombophilia. J Obstet Gynecol Neonatal Nurs. 2007;36(1):55\u201362.","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"5042_CR46","doi-asserted-by":"crossref","unstructured":"Skeith L, Rodger MA, Bates SM, Gonsalves C, Karovitch A, Taylor TS. Part of the Ritual: Exploring Patient and Physician Decision Making Regarding Anticoagulation Use in Obstetric Antiphospholipid Syndrome. Thromb Haemost. 2021;121(10):1353\u201360.","DOI":"10.1055\/a-1366-9261"},{"issue":"2","key":"5042_CR47","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.thromres.2015.05.020","volume":"136","author":"MH Eckman","year":"2015","unstructured":"Eckman MH, Alonso-Coello P, Guyatt GH, Ebrahim S, Tikkinen KAO, Lopes LC, et al. Women\u2019s values and preferences for thromboprophylaxis during pregnancy: a comparison of direct-choice and decision analysis using patient specific utilities. Thromb Res. 2015;136(2):341\u20137.","journal-title":"Thromb Res"},{"issue":"1","key":"5042_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08870449908407311","volume":"14","author":"R Horne","year":"1999","unstructured":"Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1\u201324.","journal-title":"Psychol Health"},{"issue":"6","key":"5042_CR49","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1080\/14767058.2018.1512573","volume":"33","author":"S Kai","year":"2020","unstructured":"Kai S, Fujita Y, Sato Y, Kido S, Hidaka N, Sakamoto I, et al. Pregnancy managed by unfractionated heparin after mechanical aortic valve replacement. J Matern Fetal Neonatal Med. 2020;33(6):1030\u20132.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"5042_CR50","doi-asserted-by":"crossref","unstructured":"McLintock C. Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves: No easy option. Thromb Res. 2011;127(Suppl. 3):S56\u201360.","DOI":"10.1016\/S0049-3848(11)70016-0"},{"key":"5042_CR51","unstructured":"The American College of Obstetricians and Gynecologists. ACOG Practice bulletin clinical management guidelines for obstetrician-gynecologists inherited thrombophilias in pregnancy. Obstet Gynecol. 2018;132(1):e18\u201334. Available from: https:\/\/journals.lww.com\/greenjournal"},{"issue":"1","key":"5042_CR52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejogrb.2012.12.022","volume":"168","author":"P Wu","year":"2013","unstructured":"Wu P, Poole TC, Pickett JA, Bhat A, Lees CC. Current obstetric guidelines on thromboprophylaxis in the United Kingdom: evidence based medicine? Eur J Obstetr Gynecol Reprod Biol. 2013;168(1):7\u201311.","journal-title":"Eur J Obstetr Gynecol Reprod Biol"},{"key":"5042_CR53","unstructured":"NICE clinical guideline 107. Hypertension in pregnancy the management of hypertensive disorders during pregnancy. 2010. Available from: www.nice.org.uk"},{"key":"5042_CR54","doi-asserted-by":"crossref","unstructured":"Hiligsmann M, Bours SPG, Boonen A. A review of patient preferences for osteoporosis drug treatment. Curr Rheumatol Rep. 2015;17(61):1\u201310.","DOI":"10.1007\/s11926-015-0533-0"},{"issue":"3","key":"5042_CR55","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/jep.12884","volume":"24","author":"QN Hong","year":"2018","unstructured":"Hong QN, Gonzalez-Reyes A, Pluye P. Improving the usefulness of a tool for appraising the quality of qualitative, quantitative and mixed methods studies, the mixed methods appraisal tool. J Eval Clin Pract. 2018;24(3):459\u201367.","journal-title":"J Eval Clin Pract"},{"key":"5042_CR56","doi-asserted-by":"crossref","unstructured":"Lewin S, Booth A, Glenton C, Munthe-Kaas H, Rashidian A, Wainwright M, et al. Applying GRADE-CERQual to qualitative evidence synthesis findings: Introduction to the series. Implementation Science. 2018;13:1\u201370.","DOI":"10.1186\/s13012-017-0688-3"},{"issue":"10","key":"5042_CR57","doi-asserted-by":"publisher","first-page":"742","DOI":"10.7326\/M19-1326","volume":"171","author":"C Valli","year":"2019","unstructured":"Valli C, Rabassa M, Johnston BC, Kuijpers R, Prokop-Dorner A, Zajac J, et al. Health-related values and preferences regarding meat consumption a mixed-methods systematic review. Ann Intern Med. 2019;171(10):742\u201355.","journal-title":"Ann Intern Med"},{"key":"5042_CR58","doi-asserted-by":"crossref","unstructured":"Gough D. Qualitative and mixed methods in systematic reviews. Syst Rev. 2015;4:1\u20133.","DOI":"10.1186\/s13643-015-0151-y"},{"issue":"22","key":"5042_CR59","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","volume":"2","author":"SM Bates","year":"2018","unstructured":"Bates SM, Rajasekhar A, Middeldorp S, McLintock C, Rodger MA, James AH, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv. 2018;2(22):3317\u201359.","journal-title":"Blood Adv"},{"issue":"1","key":"5042_CR60","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1538-7836.2011.04553.x","volume":"10","author":"JIP de Vries","year":"2012","unstructured":"de Vries JIP, van Pampus MG, Hague WM, Bezemer PD, Joosten JH. Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT. J Thromb Haemost. 2012;10(1):64\u201372.","journal-title":"J Thromb Haemost"},{"key":"5042_CR61","doi-asserted-by":"crossref","unstructured":"Rodger MA, Hague WM, Kingdom J, Kahn SR, Wells PS. Dalteparin for pregnant women with thrombophilia - authors\u2019 reply. Vol. 385, The Lancet. Lancet Publishing Group; 2015;385(9969):690.","DOI":"10.1016\/S0140-6736(15)60287-2"},{"issue":"1","key":"5042_CR62","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1538-7836.2008.03230.x","volume":"7","author":"E Rey","year":"2009","unstructured":"Rey E, Garneau P, David M, Gauthier R, Leduc L, Michon N, et al. Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. J Thromb Haemost. 2009;7(1):58\u201364.","journal-title":"J Thromb Haemost"},{"key":"5042_CR63","doi-asserted-by":"crossref","unstructured":"Booth A. Searching for qualitative research for inclusion in systematic reviews: A structured methodological review. Syst Rev. 2016;5(1):63\u201370.","DOI":"10.1186\/s13643-016-0249-x"},{"key":"5042_CR64","doi-asserted-by":"crossref","unstructured":"Kunneman M, Hargraves IG, Sivly AL, Branda ME, LaVecchia CM, Labrie NHM, et al. Co-creating sensible care plans using shared decision making: patients\u2019 reflections and observations of encounters. Patient Educ Couns. 2021;105(6):1539\u201344.","DOI":"10.1016\/j.pec.2021.10.003"},{"key":"5042_CR65","doi-asserted-by":"crossref","unstructured":"Noyes J, Booth A, Lewin S, Carlsen B, Glenton C, Colvin CJ, et al. Applying GRADE-CERQual to qualitative evidence synthesis findings-paper 6: How to assess relevance of the data. Implementation Science. 2018;13:51\u201361.","DOI":"10.1186\/s13012-017-0693-6"},{"key":"5042_CR66","doi-asserted-by":"crossref","unstructured":"Glenton C, Carlsen B, Lewin S, Munthe-Kaas H, Colvin CJ, Tun\u00e7alp \u00d6, et al. Applying GRADE-CERQual to qualitative evidence synthesis findings-paper 5: how to assess adequacy of data. Implementation Science. 2018;13:43\u201350.","DOI":"10.1186\/s13012-017-0692-7"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-05042-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-022-05042-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-05042-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T09:11:15Z","timestamp":1664961075000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-022-05042-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,5]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5042"],"URL":"https:\/\/doi.org\/10.1186\/s12884-022-05042-x","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,5]]},"assertion":[{"value":"7 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Nothing to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"747"}}